Cargando…
Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873237/ https://www.ncbi.nlm.nih.gov/pubmed/33563899 http://dx.doi.org/10.1038/s41408-021-00420-8 |
| _version_ | 1783649344094732288 |
|---|---|
| author | Garcia-Gutiérrez, Valentín Luna, Alejandro Alonso-Dominguez, Juan M. Estrada, Natalia Boque, Concepcion Xicoy, Blanca Giraldo, Pilar Angona, Anna Alvarez-Larrán, Alberto Sanchez-Guijo, Fermin Ramírez, María José Mora, Elvira Vélez, Patricia Rosell, Ana Colorado Araujo, Mercedes Cuevas, Beatriz Sagüés, Miguel Cortes, Montserrat Encinas, Manuel Perez Casado Montero, Luis Felipe Moreno Vega, Melania Serrano, Luis Gomez, Valle Garcia-Hernandez, Carmen Lakhwani, Sunil Paz Coll, Antonio de Paz, Raquel Suarez-Varela, Sara Fernandez-Ruiz, Andrés Perez Lopez, Raul Ortiz-Fernández, Almudena Jiménez-Velasco, Antonio Steegmann-Olmedillas, Juan Luis Hernández-Boluda, Juan Carlos |
| author_facet | Garcia-Gutiérrez, Valentín Luna, Alejandro Alonso-Dominguez, Juan M. Estrada, Natalia Boque, Concepcion Xicoy, Blanca Giraldo, Pilar Angona, Anna Alvarez-Larrán, Alberto Sanchez-Guijo, Fermin Ramírez, María José Mora, Elvira Vélez, Patricia Rosell, Ana Colorado Araujo, Mercedes Cuevas, Beatriz Sagüés, Miguel Cortes, Montserrat Encinas, Manuel Perez Casado Montero, Luis Felipe Moreno Vega, Melania Serrano, Luis Gomez, Valle Garcia-Hernandez, Carmen Lakhwani, Sunil Paz Coll, Antonio de Paz, Raquel Suarez-Varela, Sara Fernandez-Ruiz, Andrés Perez Lopez, Raul Ortiz-Fernández, Almudena Jiménez-Velasco, Antonio Steegmann-Olmedillas, Juan Luis Hernández-Boluda, Juan Carlos |
| author_sort | Garcia-Gutiérrez, Valentín |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7873237 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78732372021-02-18 Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice Garcia-Gutiérrez, Valentín Luna, Alejandro Alonso-Dominguez, Juan M. Estrada, Natalia Boque, Concepcion Xicoy, Blanca Giraldo, Pilar Angona, Anna Alvarez-Larrán, Alberto Sanchez-Guijo, Fermin Ramírez, María José Mora, Elvira Vélez, Patricia Rosell, Ana Colorado Araujo, Mercedes Cuevas, Beatriz Sagüés, Miguel Cortes, Montserrat Encinas, Manuel Perez Casado Montero, Luis Felipe Moreno Vega, Melania Serrano, Luis Gomez, Valle Garcia-Hernandez, Carmen Lakhwani, Sunil Paz Coll, Antonio de Paz, Raquel Suarez-Varela, Sara Fernandez-Ruiz, Andrés Perez Lopez, Raul Ortiz-Fernández, Almudena Jiménez-Velasco, Antonio Steegmann-Olmedillas, Juan Luis Hernández-Boluda, Juan Carlos Blood Cancer J Correspondence Nature Publishing Group UK 2021-02-09 /pmc/articles/PMC7873237/ /pubmed/33563899 http://dx.doi.org/10.1038/s41408-021-00420-8 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Garcia-Gutiérrez, Valentín Luna, Alejandro Alonso-Dominguez, Juan M. Estrada, Natalia Boque, Concepcion Xicoy, Blanca Giraldo, Pilar Angona, Anna Alvarez-Larrán, Alberto Sanchez-Guijo, Fermin Ramírez, María José Mora, Elvira Vélez, Patricia Rosell, Ana Colorado Araujo, Mercedes Cuevas, Beatriz Sagüés, Miguel Cortes, Montserrat Encinas, Manuel Perez Casado Montero, Luis Felipe Moreno Vega, Melania Serrano, Luis Gomez, Valle Garcia-Hernandez, Carmen Lakhwani, Sunil Paz Coll, Antonio de Paz, Raquel Suarez-Varela, Sara Fernandez-Ruiz, Andrés Perez Lopez, Raul Ortiz-Fernández, Almudena Jiménez-Velasco, Antonio Steegmann-Olmedillas, Juan Luis Hernández-Boluda, Juan Carlos Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice |
| title | Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice |
| title_full | Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice |
| title_fullStr | Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice |
| title_full_unstemmed | Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice |
| title_short | Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice |
| title_sort | safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873237/ https://www.ncbi.nlm.nih.gov/pubmed/33563899 http://dx.doi.org/10.1038/s41408-021-00420-8 |
| work_keys_str_mv | AT garciagutierrezvalentin safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT lunaalejandro safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT alonsodominguezjuanm safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT estradanatalia safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT boqueconcepcion safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT xicoyblanca safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT giraldopilar safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT angonaanna safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT alvarezlarranalberto safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT sanchezguijofermin safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT ramirezmariajose safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT moraelvira safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT velezpatricia safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT rosellana safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT coloradoaraujomercedes safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT cuevasbeatriz safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT saguesmiguel safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT cortesmontserrat safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT encinasmanuelperez safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT casadomonteroluisfelipe safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT morenovegamelania safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT serranoluis safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT gomezvalle safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT garciahernandezcarmen safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT lakhwanisunil safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT pazcollantonio safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT depazraquel safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT suarezvarelasara safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT fernandezruizandres safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT perezlopezraul safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT ortizfernandezalmudena safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT jimenezvelascoantonio safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT steegmannolmedillasjuanluis safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice AT hernandezboludajuancarlos safetyandefficacyofasciminibtreatmentinchronicmyeloidleukemiapatientsinreallifeclinicalpractice |